| | 27469-53-0 Basic information More.. |
| Product Name: | ALMITRINE | | Synonyms: | ALMITRINE;1-[2,4-Bis(allylamino)-1,3,5-triazin-6-yl]-4-[bis(4-fluorophenyl)methyl]piperazine;2,4-Bis(allylamino)-6-[4-[bis(p-fluorophenyl)methyl]-1-piperazinyl]-s-triazine;6-[4-[Bis(4-fluorophenyl)methyl]-1-piperazinyl]-N,N'-di(2-propenyl)-1,3,5-triazine-2,4-diamine;S-2620;AlMitrine Mesylate;Almitrine dimethanesulfonic acid;1,3,5-Triazine-2,4-diamine, 6-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]-N2,N4-di-2-propen-1-yl- | | CAS: | 27469-53-0 | | MF: | C26H29F2N7 | | MW: | 477.55 | | EINECS: | 248-475-5 | | Mol File: | 27469-53-0.mol |  |
Use
Peripheral neuropathy has been reported in a few patients
receiving almitrine for long periods. The indications for treatment have consequently been restricted in the Federal Republic of Germany. Some other
countries have advised doctors to maintain patients under close supervision
throughout treatment and to restrict dosage to two out of every three months.
- ALMITRINE USP/EP/BP
-
- US $1.10 / g
- 2021-07-28
- CAS:27469-53-0
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons min
- almitrine
-
- US $1.00 / KG
- 2020-02-01
- CAS:27469-53-0
- Min. Order: 1KG
- Purity: Min98% HPLC
- Supply Ability: G/KG/TON
|
|
27469-53-0
Recommend Suppliers |
|